Jin Medical Executes 1-for-20 Share Consolidation to Support Nasdaq Listing Compliance

Jin Medical International Ltd. ( (ZJYL) ) has shared an announcement.

Jin Medical International Ltd., a Chinese rehabilitation equipment maker focused on wheelchairs and living aids, serves domestic and international markets through a network of over 60 distributors and is expanding its manufacturing footprint with a major new facility in Anhui Province. Its product portfolio centers on lightweight, ergonomic wheelchair models aimed at users in Japan, China and other overseas markets.

On March 16, 2026, Jin Medical implemented a 1-for-20 consolidation of its Class A and Class B ordinary shares and completed a reclassification into a dual-class share structure, following shareholder approval at an extraordinary general meeting on January 30, 2026. The move, which sharply reduced the number of outstanding shares while keeping the Nasdaq ticker ZJYL unchanged, is positioned by the company as a strategic step to regain and maintain compliance with Nasdaq listing rules and to reinforce its long-term capital structure, with trading now occurring on a consolidation-adjusted basis.

More about Jin Medical International Ltd.

Jin Medical International Ltd., founded in 2006 and based in Changzhou, Jiangsu Province, China, is a leading provider of rehabilitation medical equipment, specializing in the design, development, manufacturing and marketing of wheelchairs and living aids for people with disabilities, the elderly and rehabilitation patients. The company operates two plants in Jiangsu, is building a larger facility in Anhui, and sells more than 30 wheelchair models mainly through distributors in Japan and China.

Average Trading Volume: 36,802

Technical Sentiment Signal: Strong Sell

Current Market Cap: $17.2M

For a thorough assessment of ZJYL stock, go to TipRanks’ Stock Analysis page.